Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a systematic review of the literature
Surgery is the mainstay therapy for pancreatic neuroendocrine tumors (P-NETs) but it is associated with significant adverse events. EUS-RFA has been described as a safe and effective treatment for treating P-nets. It may be reasonable to consider EUS -RFA for small P-NETS, irrespective of the functional status, we say.
